SARS‐CoV‐2 variants and spike mutations involved in second wave of COVID‐19 pandemic in India

Abstract

Against the backdrop of the second wave of COVID‐19 pandemic in India that started in March 2021, we have monitored the spike (S) protein mutations in all the reported (GISAID portal) whole‐genome sequences of SARS‐CoV‐2 circulating in India from 1 January 2021 to 31 August 2021. In the 43,102 SARS‐CoV‐2 genomic sequences analysed, we have identified 24,260 amino acid mutations in the S protein, based on which 265 Pango lineages could be categorized. The dominant lineage in most of the 28 states of India and its 8 union territories was B.1.617.2 (the delta variant). However, the states Madhya Pradesh, Jammu & Kashmir, and Punjab had B.1.1.7 (alpha variant) as the major lineage, while the Himachal Pradesh state reported B.1.36 as the dominating lineage. A detailed analysis of various domains of S protein was carried out for detecting mutations having a prevalence of >1%; 70, 18, 7, 3, 9, 4, and 1 ( N = 112) such mutations were observed in the N‐terminal domain, receptor binding domain, C ‐terminal domain, fusion peptide region, heptapeptide repeat (HR)‐1 domains, signal peptide domain, and transmembrane region, respectively. However, no mutations were recorded in the HR‐2 and cytoplasmic domains of the S protein. Interestingly, 13.39% ( N = 15) of these mutations were reported to increase the infectivity and pathogenicity of the virus; 2% ( N = 3) were known to be vaccine breakthrough mutations, and 0.89% ( N = 1) were known to escape neutralizing antibodies. The biological significance of 82% ( N = 92) of the reported mutations is yet unknown. As SARS‐CoV‐2 variants are emerging rapidly, it is critical to continuously monitor local viral mutations to understand national trends of virus circulation. This can tremendously help in designing better preventive regimens in the country, and avoid vaccine breakthrough infections.

Neutralizing Antibody Responses Elicited by Inactivated Whole Virus and Genetic Vaccines against Dominant SARS-CoV-2 Variants during the Four Epidemic Peaks of COVID-19 in Colombia

“…Finally, the L452R, T478K, and N501Y mutations were associated with nAbs resistance and higher binding affinity to the ACE2 receptor, consequently increasing viral transmissibility [28,[31][32][33]. Hence, it is possible that the reduced nAb responses against Mu, Delta, and Omicron found in our work can be partially explained by these mutations.…”

Characterization of SARS-CoV-2 Variants in Military and Civilian Personnel of an Air Force Airport during Three Pandemic Waves in Italy

“…G142D was located on the N-terminal domain of the spike protein and is involved in host cell attachment through diverse polysaccharide moieties. This mutation is known to be involved in increasing viral pathogenicity, vaccine breakthrough, and showed resistance to the mAbs [84]. S371F, in the ACE2-receptor-binding domain as well as the adjacent BA.2 specific T376A change, is reported to bear a significant fitness cost and impaired S infectivity, whilst also reducing processing efficiency and/or incorporation into viral pseudo particles [85].…”

Machine learning-based approach KEVOLVE efficiently identifies SARS-CoV-2 variant-specific genomic signatures

“…Among other notable mutations in the S protein, KEVOLVE identified the double Del156-157 and R158G substitution (highlighted by motif 3), which are located in the N-terminal domain (NTD) of the protein and are unique to the Delta variant. These mutations, known as vaccine breakthrough mutations [49], may potentially contribute to enhanced transmissibility or reduced sensitivity to pre-existing neutralizing antibodies [50]. Motif 3 also allowed the identification of the W152C and E154K mutations, which are present in more than 98% of Epsilon variants and � 80% of Kappa variants.…”